Tilaknagar Industries Ltd. (TI.NS)
INR 414.6
(1.64%)
INR 414.6
(1.64%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 13.87 Billion | 11.64 Billion | 7.79 Billion | 5.46 Billion | 6.5 Billion | 6.59 Billion |
| Cost of Revenue | 7.66 Billion | 6.16 Billion | 3.82 Billion | 2.77 Billion | 3.52 Billion | 3.19 Billion |
| Gross Profit | 6.21 Billion | 5.48 Billion | 3.96 Billion | 2.69 Billion | 2.98 Billion | 3.39 Billion |
| Operating Expenses | 3.87 Billion | 4.43 Billion | 3.08 Billion | 2.41 Billion | 3.11 Billion | 3.15 Billion |
| Selling, General and Administrative Expenses | 3.35 Billion | 378.83 Million | 1.3 Billion | 888.55 Million | 893.6 Million | 759.41 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 2.85 Billion | 75.03 Million | 12.89 Million | 29.61 Million | 249.9 Million | 8.03 Million |
| Cost and Expenses | 12.36 Billion | 10.59 Billion | 6.9 Billion | 5.19 Billion | 6.63 Billion | 6.35 Billion |
| Operating Income | 1.54 Billion | 1.13 Billion | 894.68 Million | 305.39 Million | -286.74 Million | 239.4 Million |
| Interest Expense | 267.39 Million | 401.86 Million | 487.78 Million | 460.52 Million | 1.08 Billion | 1.58 Billion |
| Income Tax Expense | - | -55 Thousand | -39.95 Million | -1.75 Million | 15.41 Million | -1.01 Million |
| Earnings before Tax | 1.38 Billion | 1.49 Billion | 411.92 Million | -385.78 Million | 2.71 Billion | -1.59 Billion |
| Net Income | 1.38 Billion | 1.49 Billion | 451.87 Million | -384.03 Million | 2.69 Billion | -1.59 Billion |
| Earnings Per Share Basic | 7.23 | 8.79 | 3.15 | -3.07 | 21.56 | -12.76 |
| Earnings Per Share Diluted | 7.16 | 8.56 | 3.08 | -3.07 | 21.49 | -12.76 |
| Weighted Average Shares Outstanding | 191 Million | 170.61 Million | 143.51 Million | 125.21 Million | 125.13 Million | 125 Million |
| Weighted Average Shares Outstanding (Diluted) | 192.87 Million | 175.06 Million | 146.68 Million | 125.21 Million | 125.51 Million | 125 Million |
| Gross Margin | 0.45 | 0.47 | 0.51 | 0.49 | 0.46 | 0.52 |
| EBIT Margin | 0.14 | 0.12 | 0.14 | 0.07 | -0.00 | 0.05 |
| Profit Margin | 0.10 | 0.13 | 0.06 | -0.07 | 0.41 | -0.24 |
| EBITDA | 1.96 Billion | 2.22 Billion | 1.35 Billion | 428.31 Million | 4.13 Billion | 359.43 Million |
| Earnings Before Tax Margin | 0.11 | 0.10 | 0.11 | 0.06 | -0.04 | 0.04 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 3.64 Billion | 3.13 Billion | 13.93 Billion | 3.58 Billion | 3.76 Billion | 3.54 Billion |
| Cost of Revenue | 2.01 Billion | 1.78 Billion | 7.87 Billion | 2.08 Billion | 1.91 Billion | 1.81 Billion |
| Gross Profit | 1.63 Billion | 1.34 Billion | 6.06 Billion | 1.5 Billion | 1.85 Billion | 1.72 Billion |
| Operating Expenses | -1.15 Billion | 919.8 Million | 4.52 Billion | 1.1 Billion | 1.41 Billion | 1.33 Billion |
| Selling, General and Administrative Expenses | - | 919.8 Million | - | 1.1 Billion | 1.22 Billion | 103.69 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -1.15 Billion | 17.4 Million | 141.38 Million | 40.59 Million | 84.29 Million | 4.82 Million |
| Cost and Expenses | 3.16 Billion | 2.7 Billion | 12.4 Billion | 3.18 Billion | 3.33 Billion | 3.15 Billion |
| Operating Income | 478.68 Million | 425.08 Million | 1.53 Billion | 403.87 Million | 518.19 Million | 396.6 Million |
| Interest Expense | - | 41.63 Million | 267.39 Million | 49.28 Million | 80.51 Million | 77.41 Million |
| Income Tax Expense | - | - | 318.76 Million | 78.36 Million | 80.04 Million | 82.33 Million |
| Earnings before Tax | 582.32 Million | 400.86 Million | 1.38 Billion | 314.51 Million | 437.68 Million | 370.43 Million |
| Net Income | 582.32 Million | 400.86 Million | 1.38 Billion | 314.51 Million | 437.68 Million | 370.43 Million |
| Earnings Per Share Basic | 3.02 | 2.08 | - | 1.65 | 2.28 | 1.93 |
| Earnings Per Share Diluted | 2.99 | 2.06 | - | 1.63 | 2.25 | 1.91 |
| Weighted Average Shares Outstanding | 192.82 Million | 192.8 Million | 191.96 Million | 191.96 Million | 191.96 Million | 191.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 194.75 Million | 194.59 Million | 194.52 Million | 194.52 Million | 194.52 Million | 193.94 Million |
| Gross Margin | 0.45 | 0.43 | 0.44 | 0.42 | 0.49 | 0.49 |
| EBIT Margin | 0.15 | 0.16 | - | 0.13 | 0.16 | 0.14 |
| Profit Margin | 0.16 | 0.13 | 0.10 | 0.09 | 0.12 | 0.10 |
| EBITDA | 556.22 Million | 502.35 Million | - | 482.28 Million | 598.2 Million | 479.06 Million |
| Earnings Before Tax Margin | 0.13 | 0.14 | 0.11 | 0.11 | 0.14 | 0.11 |
LXCHEM
RXMD
MOREPENLAB
DOM
MAXHEALTH
PHVS